WeLeader Biomedical Co

WeLeader Biomedical Co Intangible Assets

The Intangible Assets of WeLeader Biomedical Co (7713.TWO) as of Oct 15, 2026 is 4.06 M TWD. In the previous year, Intangible Assets was 3.88 M TWD — a change of 4.64% (higher).

Intangible Assets

4.06 MTWD

YoY

4.64%

Last updated:

Intangible Assets of WeLeader Biomedical Co is 2024 4.06 M TWD. Intangible Assets of WeLeader Biomedical Co was 2023 3.88 M TWD. It decreases by 4.64% higher compared to the previous year.

The WeLeader Biomedical Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2020
6.85 M TWD
Jan 1, 2021
6.13 M TWD
Jan 1, 2022
5.74 M TWD
Jan 1, 2023
3.88 M TWD
Jan 1, 2024
4.06 M TWD
The WeLeader Biomedical Co Intangible Assets history
YEARIntangible AssetsYoY
4.06 MTWD+4.64%
3.88 MTWD-32.40%
5.74 MTWD-6.47%
6.13 MTWD-10.50%
6.85 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co Ltd is a Taiwan-based company operating in the Health Care sector, specifically within Health Care Providers & Services. Headquartered in Kaohsiung, the company focuses on the agency and trading of in vitro diagnostic instruments and reagent-related products. It provides medical testing-related services, including distribution, after-sales, and maintenance for laboratory reagents, consumables, instruments, and equipment. Additionally, the company offers construction planning for medical testing laboratories, equipment procurement, operational coaching, and ancillary services such as human resources development and training. WeLeader Biomedical also develops digital medical examination platforms. The firm primarily serves the domestic market, with its products and services mainly sold within Taiwan. The company completed its initial public offering (IPO) on January 2, 2024, and is listed under the ticker symbol 7713.TWO with ISIN TW0007713000. Its website is https://www.weleader.com.tw/. The company operates in the health care industry, emphasizing diagnostic solutions and laboratory support services within Taiwan's medical infrastructure. WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WeLeader Biomedical Co stock

Intangible Assets of WeLeader Biomedical Co is 4.06 M TWD in 2024.

Intangible Assets of WeLeader Biomedical Co changed from 3.88 M TWD to 4.06 M TWD, representing a 4.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's WeLeader Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — WeLeader Biomedical Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — WeLeader Biomedical Co